Many patients report a reduction in appetite and improved blood sugar control within this time frame, which can lead to gradual weight loss
125,130 In 2022, tirzepatide was approved by the FDA for the treatment of T2DM in the United States
If you manage diabetes, watch for very high glucose (excess thirst/urination, fatigue) or low glucose (sweating, shaking, confusion) and follow your sick-day plan
Pharmacokinetics Agents vary by molecular structure and duration: Short-acting agents (e.g., exenatide twice-daily) primarily influence postprandial glucose
Try a post-workout protein smoothie
Recent FDA approvals and indications for products containing semaglutide include the reduction of cardiovascular risk in patients with type 2 diabetes and body weight reduction for obesity